INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 53 | $15.26 | 15,673 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 214 | $15.25 | 15,459 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.24 | 15,432 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 27 | $15.23 | 15,405 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 53 | $15.21 | 15,352 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
Trans History: 683
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 26 | $15.18 | 15,326 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 51 | $15.66 | 64,766 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.60 | 64,749 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 51 | $15.57 | 64,698 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.53 | 64,681 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.